E-LIB Suche - Ergebnisse für: Jäntti, Maria H.

1

Palmitate and thapsigargin have contrasting effects on ER m..:

Jäntti, Maria H. ; Jackson, Shelley N. ; Kuhn, Jeffrey...
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1867 (2022) 11 - p. 159219 , 2022

Link: https://doi.org/10.1016/..

2

Anticancer activity of the protein kinase C modulator HMI‐1..:

Jäntti, Maria H. ; Talman, Virpi ; Räsänen, Kati...
FEBS Open Bio. 8 (2018) 5 - p. 817-828 , 2018

Link: https://doi.org/10.1002/..

3

Human orexin/hypocretin receptors form constitutive homo- a..:

Jäntti, Maria H. ; Mandrika, Ilona ; Kukkonen, Jyrki P.
Biochemical and Biophysical Research Communications. 445 (2014) 2 - p. 486-490 , 2014

Link: https://doi.org/10.1016/..

4

Agonist ligand discrimination by the two orexin receptors d..:

Putula, Jaana ; Turunen, Pauli M. ; Jäntti, Maria H...
Neuroscience Letters. 494 (2011) 1 - p. 57-60 , 2011

Link: https://doi.org/10.1016/..

5

Palmitate and thapsigargin have contrasting effects on ER m..:

Jäntti, Maria H ; Jackson, Shelley N ; Kuhn, Jeffrey...
10.1016/j.bbalip.2022.159219. , 2022

Link: http://hdl.handle.net/10..

6

Palmitate and thapsigargin have contrasting effects on ER m..:

Jäntti, Maria H ; Jackson, Shelley ; Kuhn, Jeffrey...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452468/. , 2022

Link: http://www.ncbi.nlm.nih...

7

Anticancer activity of the protein kinase C modulator HMI‐1..:

Jäntti, Maria H ; Talman, Virpi ; Räsänen, Kati...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929934/. , 2018

Link: http://www.ncbi.nlm.nih...

8

Anticancer activity of the protein kinase C modulator HMI-1..:

Jantti, Maria H ; Talman, Virpi ; Räsänen, Kati...
10.1002/2211-5463.12419. , 2018

Link: http://hdl.handle.net/10..

9

Transient Receptor Potential Channels and Their Role in Mod..:

Louhivuori, Lauri M ; Jansson, Linda ; Turunen, Pauli M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356189/. , 2015

Link: http://www.ncbi.nlm.nih...

10

Nonpeptidic Oxazole-Based Prolyl Oligopeptidase Ligands wit..:

Kilpeläinen, Tommi P. ; Pätsi, Henri T. ; Svarcbahs, Reinis...
Journal of Medicinal Chemistry. 66 (2023) 11 - p. 7475-7496 , 2023

Link: https://doi.org/10.1021/..

11

Prolyl Oligopeptidase Regulates Dopamine Transporter Oligom..:

Julku, Ulrika H. ; Jäntti, Maria ; Svarcbahs, Reinis.
International Journal of Molecular Sciences. 22 (2021) 4 - p. 1777 , 2021

Link: https://doi.org/10.3390/..

12

Prolyl oligopeptidase inhibition activates autophagy via pr..:

Svarcbahs, Reinis ; Jäntti, Maria ; Kilpeläinen, Tommi...
Pharmacological Research. 151 (2020) - p. 104558 , 2020

Link: https://doi.org/10.1016/..

13

Anticancer activity of the protein kinase C modulator HMI‐1..:

Maria H. Jäntti ; Virpi Talman ; Kati Räsänen...
https://doi.org/10.1002/2211-5463.12419. , 2018

Link: https://doi.org/10.1002/..

14

Nonpeptidic Oxazole-Based Prolyl Oligopeptidase Ligands wit..:

Kilpeläinen, Tommi P ; Pätsi, Henri T ; Svarcbahs, Reinis...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258805/. , 2023

Link: http://www.ncbi.nlm.nih...

15

Nonpeptidic Oxazole-Based Prolyl Oligopeptidase Ligands wit..:

Kilpelainen, Tommi P ; Patsi, Henri T ; Svarcbahs, Reinis...
10.1021/acs.jmedchem.3c00235. , 2023

Link: http://hdl.handle.net/10..